Plain-English translation of NCT07017933 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing the JuxtaFlow® Renal Assist Device, a catheter-based system that gently supports kidney function during and after heart surgery. The device works by applying mild, controlled pressure to help your kidneys filter waste more effectively during the stressful period of surgery and recovery. Researchers believe this support may prevent kidney problems from getting worse after surgery.
Heart surgery with a heart-lung machine can put extra stress on kidneys, especially if you already have kidney problems. This stress can lead to serious complications, longer hospital stays, and higher risks. This trial exists to see whether the new treatment can protect your kidneys during this vulnerable time.
You likely qualify if…
You likely don't qualify if…
If you are accepted into the trial, you will be randomly assigned to either receive the new kidney support device or standard care during and after your heart surgery. The device group will have special catheters placed in each kidney during surgery that apply gentle negative pressure for up to 72 hours while you're in intensive care. Both groups will also have a standard bladder catheter placed. You will be monitored closely with blood tests and kidney function measurements to see how well the treatment works.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
United States
Poland